nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—psoriasis	0.399	1	CiPCiCtD
Pemetrexed—Methotrexate—psoriasis	0.254	1	CrCtD
Pemetrexed—ATIC—Methotrexate—psoriasis	0.0461	0.377	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—psoriasis	0.0366	0.299	CbGbCtD
Pemetrexed—Folic Acid—Methotrexate—psoriasis	0.0336	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—psoriasis	0.0336	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—psoriasis	0.0336	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—psoriasis	0.0336	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—psoriasis	0.0336	0.2	CrCrCtD
Pemetrexed—DHFR—Methotrexate—psoriasis	0.0234	0.191	CbGbCtD
Pemetrexed—TYMS—Methotrexate—psoriasis	0.0163	0.133	CbGbCtD
Pemetrexed—ATIC—pes—psoriasis	0.00539	0.528	CbGeAlD
Pemetrexed—ATIC—skin epidermis—psoriasis	0.00175	0.172	CbGeAlD
Pemetrexed—GART—tendon—psoriasis	0.000608	0.0596	CbGeAlD
Pemetrexed—ATIC—skin of body—psoriasis	0.000542	0.0532	CbGeAlD
Pemetrexed—GART—Purine metabolism—CAT—psoriasis	0.000522	0.0656	CbGpPWpGaD
Pemetrexed—SLC46A1—tendon—psoriasis	0.000493	0.0484	CbGeAlD
Pemetrexed—SLC46A1—Iron uptake and transport—CP—psoriasis	0.000389	0.0489	CbGpPWpGaD
Pemetrexed—TYMS—skin of body—psoriasis	0.000368	0.0361	CbGeAlD
Pemetrexed—ATIC—Purine metabolism—CAT—psoriasis	0.000362	0.0455	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—CAT—psoriasis	0.0003	0.0377	CbGpPWpGaD
Pemetrexed—TYMS—tendon—psoriasis	0.00028	0.0274	CbGeAlD
Pemetrexed—DHFR—tendon—psoriasis	0.000277	0.0272	CbGeAlD
Pemetrexed—GART—Folate Metabolism—IL4—psoriasis	0.000275	0.0346	CbGpPWpGaD
Pemetrexed—GART—Nucleotide metabolism—CAT—psoriasis	0.000262	0.033	CbGpPWpGaD
Pemetrexed—SLC29A1—tendon—psoriasis	0.000251	0.0246	CbGeAlD
Pemetrexed—DCK—tendon—psoriasis	0.00024	0.0235	CbGeAlD
Pemetrexed—GART—Folate Metabolism—CRP—psoriasis	0.000238	0.0299	CbGpPWpGaD
Pemetrexed—DHFR—G1/S-Specific Transcription—PCNA—psoriasis	0.000221	0.0278	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—ICAM1—psoriasis	0.000219	0.0275	CbGpPWpGaD
Pemetrexed—TYMS—G1/S-Specific Transcription—PCNA—psoriasis	0.000193	0.0243	CbGpPWpGaD
Pemetrexed—DCK—Purine metabolism—CAT—psoriasis	0.000188	0.0236	CbGpPWpGaD
Pemetrexed—ATIC—Nucleotide metabolism—CAT—psoriasis	0.000182	0.0229	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IFNG—psoriasis	0.000166	0.0209	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—CAT—psoriasis	0.000162	0.0203	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL4—psoriasis	0.000149	0.0187	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—NFKB1—psoriasis	0.000139	0.0174	CbGpPWpGaD
Pemetrexed—DHFR—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.00013	0.0164	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—CRP—psoriasis	0.000129	0.0162	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ICAM1—psoriasis	0.000118	0.0148	CbGpPWpGaD
Pemetrexed—TYMS—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000114	0.0143	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TNF—psoriasis	0.000108	0.0135	CbGpPWpGaD
Pemetrexed—TYMS—Vitamin A—Acitretin—psoriasis	0.000104	0.0841	CbGdCrCtD
Pemetrexed—GART—Folate Metabolism—TP53—psoriasis	9.5e-05	0.0119	CbGpPWpGaD
Pemetrexed—DCK—Nucleotide metabolism—CAT—psoriasis	9.45e-05	0.0119	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NDUFA5—psoriasis	9.33e-05	0.0117	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IFNG—psoriasis	8.99e-05	0.0113	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL6—psoriasis	8.7e-05	0.0109	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CAT—psoriasis	8.68e-05	0.0109	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IL4—psoriasis	7.98e-05	0.01	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP2S1—psoriasis	7.93e-05	0.00997	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—NFKB1—psoriasis	7.48e-05	0.0094	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	7.46e-05	0.00938	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—CP—psoriasis	7.31e-05	0.00918	CbGpPWpGaD
Pemetrexed—TYMS—Alitretinoin—Acitretin—psoriasis	7.29e-05	0.0588	CbGdCrCtD
Pemetrexed—TYMS—Isotretinoin—Acitretin—psoriasis	7.29e-05	0.0588	CbGdCrCtD
Pemetrexed—TYMS—Tretinoin—Acitretin—psoriasis	7.29e-05	0.0588	CbGdCrCtD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—psoriasis	7.08e-05	0.0089	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CRP—psoriasis	6.89e-05	0.00866	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.84e-05	0.0086	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—CAT—psoriasis	6.63e-05	0.00833	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NDUFA5—psoriasis	6.47e-05	0.00813	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—ICAM1—psoriasis	6.34e-05	0.00796	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	6e-05	0.00754	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—psoriasis	5.82e-05	0.00731	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP2S1—psoriasis	5.5e-05	0.00691	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	5.23e-05	0.00658	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—psoriasis	5.13e-05	0.00645	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NDUFA5—psoriasis	5.04e-05	0.00633	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—PCNA—psoriasis	5.01e-05	0.00629	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IFNG—psoriasis	4.82e-05	0.00606	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—psoriasis	4.79e-05	0.00602	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL6—psoriasis	4.7e-05	0.0059	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—CP—psoriasis	4.68e-05	0.00588	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.47e-05	0.00561	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—PCNA—psoriasis	4.37e-05	0.00549	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP2S1—psoriasis	4.28e-05	0.00538	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—PCNA—psoriasis	4.22e-05	0.0053	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—psoriasis	4.18e-05	0.00525	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—NFKB1—psoriasis	4.01e-05	0.00504	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CARM1—psoriasis	3.87e-05	0.00487	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PTTG1—psoriasis	3.8e-05	0.00477	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—CP—psoriasis	3.71e-05	0.00467	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—PCNA—psoriasis	3.68e-05	0.00463	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—CARM1—psoriasis	3.54e-05	0.00445	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PTTG1—psoriasis	3.4e-05	0.00427	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NDUFA5—psoriasis	3.36e-05	0.00422	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PTTG1—psoriasis	3.31e-05	0.00416	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TNF—psoriasis	3.12e-05	0.00392	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PTTG1—psoriasis	2.96e-05	0.00372	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2S1—psoriasis	2.86e-05	0.00359	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.79e-05	0.00351	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TP53—psoriasis	2.75e-05	0.00346	CbGpPWpGaD
Pemetrexed—DCK—Desoximetasone—Clobetasol propionate—psoriasis	2.75e-05	0.0221	CbGdCrCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—psoriasis	2.74e-05	0.00345	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NDUFA5—psoriasis	2.7e-05	0.0034	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CARM1—psoriasis	2.69e-05	0.00337	CbGpPWpGaD
Pemetrexed—DCK—Diflorasone—Clobetasol propionate—psoriasis	2.67e-05	0.0215	CbGdCrCtD
Pemetrexed—DHFR—Folate Metabolism—IL6—psoriasis	2.52e-05	0.00316	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Triamcinolone—psoriasis	2.5e-05	0.000667	CcSEcCtD
Pemetrexed—Shock—Prednisolone—psoriasis	2.48e-05	0.000662	CcSEcCtD
Pemetrexed—Dyspnoea—Cyclosporine—psoriasis	2.47e-05	0.00066	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	2.46e-05	0.000658	CcSEcCtD
Pemetrexed—Oedema—Hydrocortisone—psoriasis	2.46e-05	0.000658	CcSEcCtD
Pemetrexed—Anaphylactic shock—Hydrocortisone—psoriasis	2.46e-05	0.000658	CcSEcCtD
Pemetrexed—Asthenia—Mycophenolic acid—psoriasis	2.46e-05	0.000656	CcSEcCtD
Pemetrexed—Hypertension—Triamcinolone—psoriasis	2.45e-05	0.000655	CcSEcCtD
Pemetrexed—Infection—Hydrocortisone—psoriasis	2.45e-05	0.000653	CcSEcCtD
Pemetrexed—Dyspepsia—Cyclosporine—psoriasis	2.44e-05	0.000651	CcSEcCtD
Pemetrexed—Nausea—Hydroxyurea—psoriasis	2.43e-05	0.000649	CcSEcCtD
Pemetrexed—Pruritus—Mycophenolic acid—psoriasis	2.42e-05	0.000647	CcSEcCtD
Pemetrexed—Shock—Hydrocortisone—psoriasis	2.42e-05	0.000647	CcSEcCtD
Pemetrexed—Myalgia—Triamcinolone—psoriasis	2.42e-05	0.000646	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—LEP—psoriasis	2.41e-05	0.00303	CbGpPWpGaD
Pemetrexed—Nervous system disorder—Hydrocortisone—psoriasis	2.41e-05	0.000645	CcSEcCtD
Pemetrexed—Eye disorder—Prednisone—psoriasis	2.41e-05	0.000644	CcSEcCtD
Pemetrexed—Dyspnoea—Mycophenolate mofetil—psoriasis	2.41e-05	0.000643	CcSEcCtD
Pemetrexed—Decreased appetite—Cyclosporine—psoriasis	2.41e-05	0.000643	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—psoriasis	2.4e-05	0.000641	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—psoriasis	2.4e-05	0.000641	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Cyclosporine—psoriasis	2.39e-05	0.000639	CcSEcCtD
Pemetrexed—Skin disorder—Hydrocortisone—psoriasis	2.39e-05	0.000639	CcSEcCtD
Pemetrexed—Fatigue—Cyclosporine—psoriasis	2.39e-05	0.000638	CcSEcCtD
Pemetrexed—GART—Metabolism—CAT—psoriasis	2.38e-05	0.00299	CbGpPWpGaD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—psoriasis	2.38e-05	0.000636	CcSEcCtD
Pemetrexed—Dyspepsia—Mycophenolate mofetil—psoriasis	2.38e-05	0.000635	CcSEcCtD
Pemetrexed—ATIC—Levonorgestrel—Hydrocortisone—psoriasis	2.38e-05	0.0191	CbGdCrCtD
Pemetrexed—Constipation—Cyclosporine—psoriasis	2.37e-05	0.000633	CcSEcCtD
Pemetrexed—Pain—Cyclosporine—psoriasis	2.37e-05	0.000633	CcSEcCtD
Pemetrexed—Renal failure—Methotrexate—psoriasis	2.36e-05	0.00063	CcSEcCtD
Pemetrexed—TYMS—Metabolism—NDUFA5—psoriasis	2.36e-05	0.00296	CbGpPWpGaD
Pemetrexed—Decreased appetite—Mycophenolate mofetil—psoriasis	2.35e-05	0.000627	CcSEcCtD
Pemetrexed—Anorexia—Hydrocortisone—psoriasis	2.35e-05	0.000627	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.34e-05	0.00295	CbGpPWpGaD
Pemetrexed—Diarrhoea—Mycophenolic acid—psoriasis	2.34e-05	0.000626	CcSEcCtD
Pemetrexed—Stomatitis—Methotrexate—psoriasis	2.34e-05	0.000625	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—psoriasis	2.33e-05	0.000623	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	2.33e-05	0.000623	CcSEcCtD
Pemetrexed—Anaphylactic shock—Triamcinolone—psoriasis	2.32e-05	0.000619	CcSEcCtD
Pemetrexed—Oedema—Triamcinolone—psoriasis	2.32e-05	0.000619	CcSEcCtD
Pemetrexed—Syncope—Betamethasone—psoriasis	2.31e-05	0.000617	CcSEcCtD
Pemetrexed—Syncope—Dexamethasone—psoriasis	2.31e-05	0.000617	CcSEcCtD
Pemetrexed—Constipation—Mycophenolate mofetil—psoriasis	2.31e-05	0.000617	CcSEcCtD
Pemetrexed—Pain—Mycophenolate mofetil—psoriasis	2.31e-05	0.000617	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisone—psoriasis	2.3e-05	0.000615	CcSEcCtD
Pemetrexed—Infection—Triamcinolone—psoriasis	2.3e-05	0.000615	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CYP2S1—psoriasis	2.3e-05	0.00289	CbGpPWpGaD
Pemetrexed—Shock—Triamcinolone—psoriasis	2.28e-05	0.000609	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—psoriasis	2.28e-05	0.000609	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—psoriasis	2.27e-05	0.000606	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Cyclosporine—psoriasis	2.27e-05	0.000605	CcSEcCtD
Pemetrexed—Loss of consciousness—Dexamethasone—psoriasis	2.27e-05	0.000605	CcSEcCtD
Pemetrexed—Loss of consciousness—Betamethasone—psoriasis	2.27e-05	0.000605	CcSEcCtD
Pemetrexed—Dizziness—Mycophenolic acid—psoriasis	2.26e-05	0.000605	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—NOS2—psoriasis	2.25e-05	0.00283	CbGpPWpGaD
Pemetrexed—Erythema—Prednisone—psoriasis	2.24e-05	0.000599	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—psoriasis	2.24e-05	0.000599	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Hydrocortisone—psoriasis	2.24e-05	0.000599	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—psoriasis	2.24e-05	0.000598	CcSEcCtD
Pemetrexed—Hypertension—Dexamethasone—psoriasis	2.23e-05	0.000594	CcSEcCtD
Pemetrexed—Hypertension—Betamethasone—psoriasis	2.23e-05	0.000594	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	2.21e-05	0.00059	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—psoriasis	2.21e-05	0.00277	CbGpPWpGaD
Pemetrexed—Urticaria—Cyclosporine—psoriasis	2.2e-05	0.000588	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Fluocinonide—psoriasis	2.2e-05	0.0177	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Beclomethasone—psoriasis	2.2e-05	0.0177	CbGdCrCtD
Pemetrexed—Myalgia—Betamethasone—psoriasis	2.19e-05	0.000586	CcSEcCtD
Pemetrexed—Myalgia—Dexamethasone—psoriasis	2.19e-05	0.000586	CcSEcCtD
Pemetrexed—Body temperature increased—Cyclosporine—psoriasis	2.19e-05	0.000585	CcSEcCtD
Pemetrexed—Abdominal pain—Cyclosporine—psoriasis	2.19e-05	0.000585	CcSEcCtD
Pemetrexed—Vomiting—Mycophenolic acid—psoriasis	2.18e-05	0.000581	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Clobetasol propionate—psoriasis	2.18e-05	0.0175	CbGdCrCtD
Pemetrexed—Dyspepsia—Hydrocortisone—psoriasis	2.17e-05	0.000579	CcSEcCtD
Pemetrexed—Rash—Mycophenolic acid—psoriasis	2.16e-05	0.000577	CcSEcCtD
Pemetrexed—Dermatitis—Mycophenolic acid—psoriasis	2.16e-05	0.000576	CcSEcCtD
Pemetrexed—Pain—Prednisolone—psoriasis	2.16e-05	0.000576	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—psoriasis	2.16e-05	0.000575	CcSEcCtD
Pemetrexed—Urticaria—Mycophenolate mofetil—psoriasis	2.15e-05	0.000573	CcSEcCtD
Pemetrexed—Decreased appetite—Hydrocortisone—psoriasis	2.14e-05	0.000572	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—psoriasis	2.14e-05	0.000571	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Fluocinolone Acetonide—psoriasis	2.14e-05	0.0172	CbGdCrCtD
Pemetrexed—Body temperature increased—Mycophenolate mofetil—psoriasis	2.14e-05	0.000571	CcSEcCtD
Pemetrexed—Abdominal pain—Mycophenolate mofetil—psoriasis	2.14e-05	0.000571	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Fluocinonide—psoriasis	2.14e-05	0.0172	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Beclomethasone—psoriasis	2.14e-05	0.0172	CbGdCrCtD
Pemetrexed—Urinary tract disorder—Methotrexate—psoriasis	2.13e-05	0.000568	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.13e-05	0.000568	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Clobetasol propionate—psoriasis	2.12e-05	0.0171	CbGdCrCtD
Pemetrexed—Fatigue—Hydrocortisone—psoriasis	2.12e-05	0.000567	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—psoriasis	2.11e-05	0.000564	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.11e-05	0.000564	CcSEcCtD
Pemetrexed—Pain—Hydrocortisone—psoriasis	2.11e-05	0.000562	CcSEcCtD
Pemetrexed—Oedema—Betamethasone—psoriasis	2.1e-05	0.000562	CcSEcCtD
Pemetrexed—Anaphylactic shock—Betamethasone—psoriasis	2.1e-05	0.000562	CcSEcCtD
Pemetrexed—Oedema—Dexamethasone—psoriasis	2.1e-05	0.000562	CcSEcCtD
Pemetrexed—Anaphylactic shock—Dexamethasone—psoriasis	2.1e-05	0.000562	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—PPARG—psoriasis	2.1e-05	0.00264	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CARM1—psoriasis	2.09e-05	0.00263	CbGpPWpGaD
Pemetrexed—Infection—Dexamethasone—psoriasis	2.09e-05	0.000558	CcSEcCtD
Pemetrexed—Infection—Betamethasone—psoriasis	2.09e-05	0.000558	CcSEcCtD
Pemetrexed—Anaemia—Prednisone—psoriasis	2.07e-05	0.000554	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Fluocinolone Acetonide—psoriasis	2.07e-05	0.0167	CbGdCrCtD
Pemetrexed—Shock—Betamethasone—psoriasis	2.07e-05	0.000553	CcSEcCtD
Pemetrexed—Shock—Dexamethasone—psoriasis	2.07e-05	0.000553	CcSEcCtD
Pemetrexed—Dyspnoea—Triamcinolone—psoriasis	2.07e-05	0.000552	CcSEcCtD
Pemetrexed—Nervous system disorder—Dexamethasone—psoriasis	2.06e-05	0.000551	CcSEcCtD
Pemetrexed—Nervous system disorder—Betamethasone—psoriasis	2.06e-05	0.000551	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dexamethasone—psoriasis	2.06e-05	0.00055	CcSEcCtD
Pemetrexed—Thrombocytopenia—Betamethasone—psoriasis	2.06e-05	0.00055	CcSEcCtD
Pemetrexed—Hypersensitivity—Cyclosporine—psoriasis	2.04e-05	0.000545	CcSEcCtD
Pemetrexed—Dyspepsia—Triamcinolone—psoriasis	2.04e-05	0.000545	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—psoriasis	2.04e-05	0.000544	CcSEcCtD
Pemetrexed—Nausea—Mycophenolic acid—psoriasis	2.03e-05	0.000543	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—psoriasis	2.01e-05	0.000538	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Hydrocortisone—psoriasis	2.01e-05	0.000538	CcSEcCtD
Pemetrexed—Syncope—Prednisone—psoriasis	2.01e-05	0.000538	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Clobetasol propionate—psoriasis	2.01e-05	0.0162	CbGdCrCtD
Pemetrexed—Anorexia—Betamethasone—psoriasis	2.01e-05	0.000535	CcSEcCtD
Pemetrexed—Anorexia—Dexamethasone—psoriasis	2.01e-05	0.000535	CcSEcCtD
Pemetrexed—TYMS—Metabolism—CYP2S1—psoriasis	2e-05	0.00252	CbGpPWpGaD
Pemetrexed—Urticaria—Prednisolone—psoriasis	2e-05	0.000535	CcSEcCtD
Pemetrexed—Fatigue—Triamcinolone—psoriasis	2e-05	0.000534	CcSEcCtD
Pemetrexed—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.99e-05	0.000532	CcSEcCtD
Pemetrexed—Asthenia—Cyclosporine—psoriasis	1.99e-05	0.000531	CcSEcCtD
Pemetrexed—Pain—Triamcinolone—psoriasis	1.98e-05	0.000529	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—psoriasis	1.97e-05	0.000527	CcSEcCtD
Pemetrexed—Pruritus—Cyclosporine—psoriasis	1.96e-05	0.000523	CcSEcCtD
Pemetrexed—Urticaria—Hydrocortisone—psoriasis	1.96e-05	0.000522	CcSEcCtD
Pemetrexed—Abdominal pain—Hydrocortisone—psoriasis	1.95e-05	0.00052	CcSEcCtD
Pemetrexed—Body temperature increased—Hydrocortisone—psoriasis	1.95e-05	0.00052	CcSEcCtD
Pemetrexed—Asthenia—Mycophenolate mofetil—psoriasis	1.94e-05	0.000518	CcSEcCtD
Pemetrexed—Hypertension—Prednisone—psoriasis	1.94e-05	0.000518	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—psoriasis	1.92e-05	0.00242	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Betamethasone—psoriasis	1.92e-05	0.000512	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.92e-05	0.000512	CcSEcCtD
Pemetrexed—Pruritus—Mycophenolate mofetil—psoriasis	1.91e-05	0.000511	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—psoriasis	1.91e-05	0.00051	CcSEcCtD
Pemetrexed—Myalgia—Prednisone—psoriasis	1.91e-05	0.00051	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—psoriasis	1.9e-05	0.000509	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.9e-05	0.000507	CcSEcCtD
Pemetrexed—Diarrhoea—Cyclosporine—psoriasis	1.9e-05	0.000506	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—psoriasis	1.88e-05	0.000501	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—psoriasis	1.88e-05	0.000501	CcSEcCtD
Pemetrexed—Hypersensitivity—Prednisolone—psoriasis	1.86e-05	0.000496	CcSEcCtD
Pemetrexed—Dyspepsia—Dexamethasone—psoriasis	1.85e-05	0.000495	CcSEcCtD
Pemetrexed—Dyspepsia—Betamethasone—psoriasis	1.85e-05	0.000495	CcSEcCtD
Pemetrexed—GART—Metabolism—APOE—psoriasis	1.85e-05	0.00233	CbGpPWpGaD
Pemetrexed—Diarrhoea—Mycophenolate mofetil—psoriasis	1.85e-05	0.000494	CcSEcCtD
Pemetrexed—Urticaria—Triamcinolone—psoriasis	1.84e-05	0.000492	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—psoriasis	1.84e-05	0.000491	CcSEcCtD
Pemetrexed—Body temperature increased—Triamcinolone—psoriasis	1.83e-05	0.000489	CcSEcCtD
Pemetrexed—Dizziness—Cyclosporine—psoriasis	1.83e-05	0.000489	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—psoriasis	1.83e-05	0.000489	CcSEcCtD
Pemetrexed—Oedema—Prednisone—psoriasis	1.83e-05	0.000489	CcSEcCtD
Pemetrexed—Decreased appetite—Dexamethasone—psoriasis	1.83e-05	0.000488	CcSEcCtD
Pemetrexed—Decreased appetite—Betamethasone—psoriasis	1.83e-05	0.000488	CcSEcCtD
Pemetrexed—Infection—Prednisone—psoriasis	1.82e-05	0.000486	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Betamethasone—psoriasis	1.82e-05	0.000485	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Dexamethasone—psoriasis	1.82e-05	0.000485	CcSEcCtD
Pemetrexed—Hypersensitivity—Hydrocortisone—psoriasis	1.81e-05	0.000484	CcSEcCtD
Pemetrexed—Fatigue—Betamethasone—psoriasis	1.81e-05	0.000484	CcSEcCtD
Pemetrexed—Fatigue—Dexamethasone—psoriasis	1.81e-05	0.000484	CcSEcCtD
Pemetrexed—Shock—Prednisone—psoriasis	1.8e-05	0.000481	CcSEcCtD
Pemetrexed—Pain—Dexamethasone—psoriasis	1.8e-05	0.00048	CcSEcCtD
Pemetrexed—Pain—Betamethasone—psoriasis	1.8e-05	0.00048	CcSEcCtD
Pemetrexed—Nervous system disorder—Prednisone—psoriasis	1.8e-05	0.00048	CcSEcCtD
Pemetrexed—Dizziness—Mycophenolate mofetil—psoriasis	1.79e-05	0.000477	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Beclomethasone—psoriasis	1.79e-05	0.0144	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Fluocinonide—psoriasis	1.79e-05	0.0144	CbGdCrCtD
Pemetrexed—Skin disorder—Prednisone—psoriasis	1.78e-05	0.000475	CcSEcCtD
Pemetrexed—Asthenia—Hydrocortisone—psoriasis	1.77e-05	0.000472	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Fluocinonide—psoriasis	1.76e-05	0.0142	CbGdCrCtD
Pemetrexed—Vomiting—Cyclosporine—psoriasis	1.76e-05	0.00047	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Clobetasol propionate—psoriasis	1.76e-05	0.0142	CbGdCrCtD
Pemetrexed—Rash—Cyclosporine—psoriasis	1.75e-05	0.000466	CcSEcCtD
Pemetrexed—Anorexia—Prednisone—psoriasis	1.75e-05	0.000466	CcSEcCtD
Pemetrexed—Dermatitis—Cyclosporine—psoriasis	1.75e-05	0.000466	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Beclomethasone—psoriasis	1.74e-05	0.0141	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Fluocinonide—psoriasis	1.74e-05	0.0141	CbGdCrCtD
Pemetrexed—Pruritus—Hydrocortisone—psoriasis	1.74e-05	0.000465	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	1.73e-05	0.014	CbGdCrCtD
Pemetrexed—Anaemia—Methotrexate—psoriasis	1.73e-05	0.000463	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dexamethasone—psoriasis	1.72e-05	0.000459	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Betamethasone—psoriasis	1.72e-05	0.000459	CcSEcCtD
Pemetrexed—Vomiting—Mycophenolate mofetil—psoriasis	1.72e-05	0.000459	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Fluocinolone Acetonide—psoriasis	1.71e-05	0.0138	CbGdCrCtD
Pemetrexed—Hypersensitivity—Triamcinolone—psoriasis	1.71e-05	0.000456	CcSEcCtD
Pemetrexed—Rash—Mycophenolate mofetil—psoriasis	1.7e-05	0.000455	CcSEcCtD
Pemetrexed—Dermatitis—Mycophenolate mofetil—psoriasis	1.7e-05	0.000455	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Beclomethasone—psoriasis	1.7e-05	0.0137	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Fluocinonide—psoriasis	1.7e-05	0.0137	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Fluocinolone Acetonide—psoriasis	1.69e-05	0.0137	CbGdCrCtD
Pemetrexed—Diarrhoea—Hydrocortisone—psoriasis	1.68e-05	0.00045	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—psoriasis	1.68e-05	0.000448	CcSEcCtD
Pemetrexed—Urticaria—Dexamethasone—psoriasis	1.67e-05	0.000446	CcSEcCtD
Pemetrexed—Urticaria—Betamethasone—psoriasis	1.67e-05	0.000446	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Prednisone—psoriasis	1.67e-05	0.000446	CcSEcCtD
Pemetrexed—Dizziness—Prednisolone—psoriasis	1.67e-05	0.000445	CcSEcCtD
Pemetrexed—Asthenia—Triamcinolone—psoriasis	1.66e-05	0.000444	CcSEcCtD
Pemetrexed—Body temperature increased—Dexamethasone—psoriasis	1.66e-05	0.000444	CcSEcCtD
Pemetrexed—Body temperature increased—Betamethasone—psoriasis	1.66e-05	0.000444	CcSEcCtD
Pemetrexed—Abdominal pain—Betamethasone—psoriasis	1.66e-05	0.000444	CcSEcCtD
Pemetrexed—Abdominal pain—Dexamethasone—psoriasis	1.66e-05	0.000444	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	1.65e-05	0.0133	CbGdCrCtD
Pemetrexed—ATIC—Metabolism—CAT—psoriasis	1.65e-05	0.00208	CbGpPWpGaD
Pemetrexed—Nausea—Cyclosporine—psoriasis	1.65e-05	0.000439	CcSEcCtD
Pemetrexed—Pruritus—Triamcinolone—psoriasis	1.64e-05	0.000438	CcSEcCtD
Pemetrexed—Dizziness—Hydrocortisone—psoriasis	1.63e-05	0.000435	CcSEcCtD
Pemetrexed—Dyspepsia—Prednisone—psoriasis	1.61e-05	0.000431	CcSEcCtD
Pemetrexed—GART—Metabolism—PPARG—psoriasis	1.61e-05	0.00203	CbGpPWpGaD
Pemetrexed—TYMS—Diflorasone—Beclomethasone—psoriasis	1.61e-05	0.013	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Fluocinonide—psoriasis	1.61e-05	0.013	CbGdCrCtD
Pemetrexed—Nausea—Mycophenolate mofetil—psoriasis	1.61e-05	0.000429	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—psoriasis	1.6e-05	0.000427	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—psoriasis	1.6e-05	0.000427	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—psoriasis	1.6e-05	0.000427	CcSEcCtD
Pemetrexed—Decreased appetite—Prednisone—psoriasis	1.59e-05	0.000425	CcSEcCtD
Pemetrexed—Rash—Prednisolone—psoriasis	1.59e-05	0.000424	CcSEcCtD
Pemetrexed—Dermatitis—Prednisolone—psoriasis	1.59e-05	0.000424	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.59e-05	0.000424	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—psoriasis	1.58e-05	0.000422	CcSEcCtD
Pemetrexed—Constipation—Prednisone—psoriasis	1.57e-05	0.000418	CcSEcCtD
Pemetrexed—Vomiting—Hydrocortisone—psoriasis	1.57e-05	0.000418	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Fluocinolone Acetonide—psoriasis	1.56e-05	0.0126	CbGdCrCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.55e-05	0.00195	CbGpPWpGaD
Pemetrexed—Rash—Hydrocortisone—psoriasis	1.55e-05	0.000415	CcSEcCtD
Pemetrexed—Dermatitis—Hydrocortisone—psoriasis	1.55e-05	0.000414	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PCNA—psoriasis	1.55e-05	0.00195	CbGpPWpGaD
Pemetrexed—Dizziness—Triamcinolone—psoriasis	1.53e-05	0.000409	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—psoriasis	1.53e-05	0.000409	CcSEcCtD
Pemetrexed—Infection—Methotrexate—psoriasis	1.52e-05	0.000406	CcSEcCtD
Pemetrexed—Asthenia—Dexamethasone—psoriasis	1.51e-05	0.000403	CcSEcCtD
Pemetrexed—Asthenia—Betamethasone—psoriasis	1.51e-05	0.000403	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—psoriasis	1.5e-05	0.000401	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—psoriasis	1.5e-05	0.0004	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Prednisone—psoriasis	1.5e-05	0.0004	CcSEcCtD
Pemetrexed—Nausea—Prednisolone—psoriasis	1.5e-05	0.0004	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.5e-05	0.00188	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—JUN—psoriasis	1.49e-05	0.00187	CbGpPWpGaD
Pemetrexed—Pruritus—Dexamethasone—psoriasis	1.49e-05	0.000397	CcSEcCtD
Pemetrexed—Pruritus—Betamethasone—psoriasis	1.49e-05	0.000397	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—psoriasis	1.49e-05	0.000397	CcSEcCtD
Pemetrexed—Vomiting—Triamcinolone—psoriasis	1.47e-05	0.000394	CcSEcCtD
Pemetrexed—Nausea—Hydrocortisone—psoriasis	1.46e-05	0.000391	CcSEcCtD
Pemetrexed—Rash—Triamcinolone—psoriasis	1.46e-05	0.00039	CcSEcCtD
Pemetrexed—Dermatitis—Triamcinolone—psoriasis	1.46e-05	0.00039	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—psoriasis	1.46e-05	0.00039	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—psoriasis	1.46e-05	0.000389	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—psoriasis	1.45e-05	0.000387	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—psoriasis	1.45e-05	0.000387	CcSEcCtD
Pemetrexed—Diarrhoea—Betamethasone—psoriasis	1.44e-05	0.000384	CcSEcCtD
Pemetrexed—Diarrhoea—Dexamethasone—psoriasis	1.44e-05	0.000384	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Beclomethasone—psoriasis	1.41e-05	0.0114	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Fluocinonide—psoriasis	1.41e-05	0.0114	CbGdCrCtD
Pemetrexed—DCK—Metabolism—CARM1—psoriasis	1.4e-05	0.00175	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—psoriasis	1.4e-05	0.000373	CcSEcCtD
Pemetrexed—Dizziness—Betamethasone—psoriasis	1.39e-05	0.000371	CcSEcCtD
Pemetrexed—Dizziness—Dexamethasone—psoriasis	1.39e-05	0.000371	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—PCNA—psoriasis	1.38e-05	0.00174	CbGpPWpGaD
Pemetrexed—Nausea—Triamcinolone—psoriasis	1.38e-05	0.000368	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Fluocinolone Acetonide—psoriasis	1.37e-05	0.011	CbGdCrCtD
Pemetrexed—Dyspnoea—Methotrexate—psoriasis	1.37e-05	0.000365	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.36e-05	0.00171	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PCNA—psoriasis	1.35e-05	0.0017	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Prednisone—psoriasis	1.35e-05	0.00036	CcSEcCtD
Pemetrexed—Dyspepsia—Methotrexate—psoriasis	1.35e-05	0.00036	CcSEcCtD
Pemetrexed—Vomiting—Betamethasone—psoriasis	1.34e-05	0.000357	CcSEcCtD
Pemetrexed—Vomiting—Dexamethasone—psoriasis	1.34e-05	0.000357	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—psoriasis	1.33e-05	0.000355	CcSEcCtD
Pemetrexed—Rash—Betamethasone—psoriasis	1.33e-05	0.000354	CcSEcCtD
Pemetrexed—Rash—Dexamethasone—psoriasis	1.33e-05	0.000354	CcSEcCtD
Pemetrexed—Dermatitis—Dexamethasone—psoriasis	1.33e-05	0.000354	CcSEcCtD
Pemetrexed—Dermatitis—Betamethasone—psoriasis	1.33e-05	0.000354	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—psoriasis	1.32e-05	0.000353	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—psoriasis	1.32e-05	0.000353	CcSEcCtD
Pemetrexed—Asthenia—Prednisone—psoriasis	1.31e-05	0.000351	CcSEcCtD
Pemetrexed—Pain—Methotrexate—psoriasis	1.31e-05	0.00035	CcSEcCtD
Pemetrexed—Pruritus—Prednisone—psoriasis	1.3e-05	0.000346	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CAT—psoriasis	1.29e-05	0.00162	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—psoriasis	1.28e-05	0.00161	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HLA-A—psoriasis	1.28e-05	0.00161	CbGpPWpGaD
Pemetrexed—Diarrhoea—Prednisone—psoriasis	1.25e-05	0.000335	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—psoriasis	1.25e-05	0.000334	CcSEcCtD
Pemetrexed—Nausea—Betamethasone—psoriasis	1.25e-05	0.000334	CcSEcCtD
Pemetrexed—Nausea—Dexamethasone—psoriasis	1.25e-05	0.000334	CcSEcCtD
Pemetrexed—Urticaria—Methotrexate—psoriasis	1.22e-05	0.000325	CcSEcCtD
Pemetrexed—Dizziness—Prednisone—psoriasis	1.21e-05	0.000324	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—psoriasis	1.21e-05	0.000323	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—psoriasis	1.21e-05	0.000323	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—PCNA—psoriasis	1.21e-05	0.00152	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—psoriasis	1.19e-05	0.0015	CbGpPWpGaD
Pemetrexed—Vomiting—Prednisone—psoriasis	1.16e-05	0.000311	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.16e-05	0.00146	CbGpPWpGaD
Pemetrexed—Rash—Prednisone—psoriasis	1.16e-05	0.000308	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—psoriasis	1.15e-05	0.000308	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—psoriasis	1.13e-05	0.000301	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CARM1—psoriasis	1.12e-05	0.00141	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—psoriasis	1.12e-05	0.0014	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS2—psoriasis	1.11e-05	0.0014	CbGpPWpGaD
Pemetrexed—Asthenia—Methotrexate—psoriasis	1.1e-05	0.000293	CcSEcCtD
Pemetrexed—Nausea—Prednisone—psoriasis	1.09e-05	0.000291	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—psoriasis	1.08e-05	0.000289	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Hydrocortisone—psoriasis	1.08e-05	0.0087	CbGdCrCtD
Pemetrexed—Diarrhoea—Methotrexate—psoriasis	1.05e-05	0.00028	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.03e-05	0.00129	CbGpPWpGaD
Pemetrexed—Dizziness—Methotrexate—psoriasis	1.01e-05	0.00027	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Betamethasone—psoriasis	1e-05	0.00808	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Dexamethasone—psoriasis	1e-05	0.00808	CbGdCrCtD
Pemetrexed—SLC46A1—Metabolism—APOE—psoriasis	1e-05	0.00126	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—psoriasis	9.85e-06	0.00124	CbGpPWpGaD
Pemetrexed—DCK—Desoximetasone—Triamcinolone—psoriasis	9.8e-06	0.00789	CbGdCrCtD
Pemetrexed—TYMS—Metabolism—CARM1—psoriasis	9.79e-06	0.00123	CbGpPWpGaD
Pemetrexed—Vomiting—Methotrexate—psoriasis	9.74e-06	0.00026	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Dexamethasone—psoriasis	9.73e-06	0.00784	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Betamethasone—psoriasis	9.73e-06	0.00784	CbGdCrCtD
Pemetrexed—Rash—Methotrexate—psoriasis	9.65e-06	0.000258	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—psoriasis	9.65e-06	0.000258	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Triamcinolone—psoriasis	9.51e-06	0.00766	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Prednisone—psoriasis	9.3e-06	0.00749	CbGdCrCtD
Pemetrexed—SLC46A1—Disease—TYK2—psoriasis	9.11e-06	0.00115	CbGpPWpGaD
Pemetrexed—Nausea—Methotrexate—psoriasis	9.09e-06	0.000243	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisolone—psoriasis	9.07e-06	0.00731	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Prednisone—psoriasis	9.02e-06	0.00727	CbGdCrCtD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—psoriasis	9.01e-06	0.00113	CbGpPWpGaD
Pemetrexed—DCK—Diflorasone—Prednisolone—psoriasis	8.81e-06	0.0071	CbGdCrCtD
Pemetrexed—SLC46A1—Metabolism—PPARG—psoriasis	8.71e-06	0.00109	CbGpPWpGaD
Pemetrexed—TYMS—Flunisolide—Hydrocortisone—psoriasis	8.65e-06	0.00697	CbGdCrCtD
Pemetrexed—DCK—Metabolism—CAT—psoriasis	8.59e-06	0.00108	CbGpPWpGaD
Pemetrexed—TYMS—Triamcinolone—Hydrocortisone—psoriasis	8.56e-06	0.0069	CbGdCrCtD
Pemetrexed—SLC46A1—Disease—CD4—psoriasis	8.24e-06	0.00104	CbGpPWpGaD
Pemetrexed—TYMS—Clobetasol propionate—Dexamethasone—psoriasis	8.14e-06	0.00656	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Betamethasone—psoriasis	8.14e-06	0.00656	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Dexamethasone—psoriasis	8.03e-06	0.00647	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Betamethasone—psoriasis	8.03e-06	0.00647	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Triamcinolone—psoriasis	7.95e-06	0.00641	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Dexamethasone—psoriasis	7.95e-06	0.0064	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Betamethasone—psoriasis	7.95e-06	0.0064	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Triamcinolone—psoriasis	7.85e-06	0.00632	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Dexamethasone—psoriasis	7.75e-06	0.00625	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Betamethasone—psoriasis	7.75e-06	0.00625	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Triamcinolone—psoriasis	7.57e-06	0.0061	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—psoriasis	7.55e-06	0.00608	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Prednisone—psoriasis	7.45e-06	0.006	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—psoriasis	7.37e-06	0.00594	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisolone—psoriasis	7.36e-06	0.00593	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Betamethasone—psoriasis	7.33e-06	0.0059	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Dexamethasone—psoriasis	7.33e-06	0.0059	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Prednisolone—psoriasis	7.27e-06	0.00586	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisolone—psoriasis	7.19e-06	0.0058	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Triamcinolone—psoriasis	7.16e-06	0.00577	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Hydrocortisone—psoriasis	6.92e-06	0.00557	CbGdCrCtD
Pemetrexed—DHFR—Metabolism—CAT—psoriasis	6.9e-06	0.000867	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HLA-A—psoriasis	6.86e-06	0.000862	CbGpPWpGaD
Pemetrexed—TYMS—Diflorasone—Prednisone—psoriasis	6.79e-06	0.00547	CbGdCrCtD
Pemetrexed—DCK—Metabolism—APOE—psoriasis	6.67e-06	0.000838	CbGpPWpGaD
Pemetrexed—TYMS—Diflorasone—Prednisolone—psoriasis	6.63e-06	0.00534	CbGdCrCtD
Pemetrexed—TYMS—Danazol—Hydrocortisone—psoriasis	6.63e-06	0.00534	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Betamethasone—psoriasis	6.42e-06	0.00518	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Dexamethasone—psoriasis	6.42e-06	0.00518	CbGdCrCtD
Pemetrexed—DHFR—Disease—APOE—psoriasis	6.4e-06	0.000804	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—psoriasis	6.38e-06	0.000802	CbGpPWpGaD
Pemetrexed—DCK—Levonorgestrel—Hydrocortisone—psoriasis	6.31e-06	0.00509	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Triamcinolone—psoriasis	6.28e-06	0.00506	CbGdCrCtD
Pemetrexed—TYMS—Metabolism—CAT—psoriasis	6.02e-06	0.000757	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—psoriasis	5.97e-06	0.00075	CbGpPWpGaD
Pemetrexed—TYMS—Budesonide—Prednisone—psoriasis	5.96e-06	0.0048	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Prednisolone—psoriasis	5.81e-06	0.00468	CbGdCrCtD
Pemetrexed—DCK—Metabolism—PPARG—psoriasis	5.81e-06	0.00073	CbGpPWpGaD
Pemetrexed—TYMS—Danazol—Prednisone—psoriasis	5.71e-06	0.0046	CbGdCrCtD
Pemetrexed—DHFR—Metabolism—APOE—psoriasis	5.36e-06	0.000674	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—psoriasis	5.09e-06	0.00064	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TYK2—psoriasis	4.89e-06	0.000614	CbGpPWpGaD
Pemetrexed—TYMS—Levonorgestrel—Hydrocortisone—psoriasis	4.75e-06	0.00383	CbGdCrCtD
Pemetrexed—TYMS—Metabolism—APOE—psoriasis	4.68e-06	0.000588	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—psoriasis	4.67e-06	0.000587	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—psoriasis	4.46e-06	0.00056	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—psoriasis	4.44e-06	0.000558	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—psoriasis	4.42e-06	0.000555	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—psoriasis	4.07e-06	0.000512	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—psoriasis	3.42e-06	0.00043	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—psoriasis	2.39e-06	0.0003	CbGpPWpGaD
